Is switching to T-DM1 still justified in HER2-negative residual breast cancer after neoadjuvant systemic therapy?
Source
The Breast - ISSN 0960-9776-81 (2025) p. 1-2
Correspondence on "The prognostic value of tumor-infiltrating lymphocytes in vulvovaginal melanoma" by Vanbockstael et al
Source
International journal of gynecological cancer - ISSN 1048-891X-35:6 (2025) p. 1-1
Detection of actionable mutations in circulating tumor DNA for non-small cell lung cancer patients
Source
Communications medicine - ISSN 2730-664X-5:1 (2025) p. 1-10
A plain language summary of POLARIS : a study to look at different doses of encorafenib plus binimetinib for people with BRAF V600-mutant melanoma with brain metastasis
Source
Future oncology - ISSN 1479-6694- (2025) p.
Comparison of inter- and intraobserver agreement between [¹⁸F]AlF-NOTA-octreotide and [⁶⁸Ga]Ga-DOTA-SSA PET/CT
Source
EJNMMI reports - ISSN 3005-074X-9:1 (2025) p. 1-15